Unraveling the NALP-3/IL-1beta inflammasome: a big lesson from a small mutation

Charles A Dinarello1

  • 1University Colorado Health Sciences Center, Division of Infectious Diseases, B168, 4200 East Ninth Avenue, Denver, CO 80262, USA.

Immunity
|March 20, 2004
PubMed

Insights

A mutation in the NALP-3 gene causes increased inflammatory cytokine release. Blocking interleukin-1 (IL-1) receptors effectively halts inflammation in affected individuals, offering a potential therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Cytokine-mediated inflammation is a key area for therapeutic development and basic research.
  • The NALP-3 inflammasome plays a critical role in regulating inflammatory responses.

Purpose of the Study:

  • To investigate the impact of a specific NALP-3 gene mutation on inflammatory pathways.
  • To evaluate the efficacy of blocking interleukin-1 (IL-1) signaling in mitigating inflammation associated with this mutation.

Main Methods:

  • Genetic analysis of the NALP-3 gene.
  • Assay of caspase-1 activation and IL-1beta processing.
  • Pharmacological blockade of IL-1 receptors.

Main Results:

  • A single amino acid mutation in NALP-3 was identified.
  • This mutation leads to enhanced processing of the inactive IL-1beta precursor.
  • The release of active IL-1beta cytokine was significantly increased.
  • Blocking IL-1 receptors successfully arrested inflammation in affected humans.

Conclusions:

  • The NALP-3 gene mutation is directly linked to excessive IL-1beta production and inflammation.
  • Targeting IL-1 receptors represents a viable therapeutic strategy for managing NALP-3-associated inflammatory conditions.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Mechanism of Lamellipodia Formation01:31

Mechanism of Lamellipodia Formation

Cells migrating in response to external stimuli form lamellipodia, which are thin membrane protrusions supported by a mesh of linked, branched, or unbranched actin filaments. These actin filaments interact with myosin motor proteins, creating the dynamic actomyosin complex within the cytoskeleton. Contractility, or the ability to generate contractile stress, is inherent to the actomyosin complex. It helps cells detect the stiffness of the surrounding ECM and exert contractile force for...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...